Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare
A Florida judge ordered a C‑section for Cherise Doyley, a Black doula who had requested a vaginal birth after three prior cesareans. The decision stemmed from state fetal‑personhood statutes and ACOG guidelines that expose physicians to liability for deviating from standard practice. The case underscores how post‑Dobbs legal frameworks are intruding on patient autonomy and amplifying existing racial disparities in maternal care. It also highlights the urgent need for legal safeguards and a more diverse obstetric workforce.
DHSC Outlines Future of Fingertips Health Data Repository in £1.25m Contract
The UK Department of Health and Social Care has awarded a £1.25 million (≈ $1.59 million) contract to Marvell Consulting to build a public‑beta "Find Public Health Data" service that will replace the aging Fingertips platform. Hosted on Microsoft Azure, the new service...
Macmillan Calls for Fairer Cancer Care in AMV Campaign
Macmillan Cancer Support has launched a year‑long “Fair Cancer Care” campaign developed by AMV BBDO to spotlight how geography, income and background shape cancer experiences. The initiative rolls out with a 60‑second TV spot aired during the Great British Bake Off ad...
Nuvalent Reports the US FDA’s NDA Submission for Neladalkib to Treat ALK-Positive NSCLC
Nuvalent has submitted a New Drug Application to the U.S. FDA for neladalkib, an ALK‑selective inhibitor intended for patients with advanced ALK‑positive non‑small cell lung cancer (NSCLC) who have progressed after prior tyrosine‑kinase inhibitor (TKI) therapy. The filing is backed...
Choking First Aid: What You Should Know Before an Emergency Happens
Choking ranks as the fourth leading cause of unintentional injury death worldwide, and survival hinges on actions taken in the first minutes. The article outlines the distinct signs of partial versus complete airway obstruction and stresses the five‑and‑five cycle of...
How Modern Aesthetic Technology Is Changing the Way We Approach Skin Health
Modern aesthetic medicine has shifted from surgery‑centric procedures to a rapidly expanding suite of non‑invasive, device‑based technologies that target skin health at a structural level. Energy‑based platforms such as radiofrequency, high‑intensity focused ultrasound, lasers and light devices now dominate clinical...
NHS Grampian Highlights 12 Digital Priority Programmes for Delivery in 2026/27
NHS Grampian has mapped out twelve digital priority programmes for 2026/27, spanning the MyCare.scot front‑door portal, a national child health record, Microsoft 365, Windows 10 replacement, PACS and RIS imaging platforms, INFIX theatre scheduling, LIMS, GP IT and core infrastructure upgrades....
Gloucestershire Royal Hospital Expands Cardiac Pacing Services with Specialist Angiography X-Ray System
Gloucestershire Royal Hospital has installed Canon Medical’s Alphenix Core+ angiography X‑ray system to expand its cardiac pacing services. The new system supports around 700 pacemaker implantations, 300 rhythm procedures and 2,000 angiograms annually, while offering ultra‑low radiation and AI‑driven image...
Volunteer Responder App Piloted Across 46 Community First Responder Schemes in Scotland
The Scottish Ambulance Service piloted a new volunteer responder app across 46 Community First Responder schemes from November 2025 to February 2026. The trial delivered a 36% increase in volunteer incident responses, equating to 786 more patients assisted, and saw...
5 Reasons Why the Medicare Program Can’t Go Broke
President Trump claimed the federal government can’t afford Medicare, echoing a long‑standing political narrative that the program faces inevitable insolvency. The article dismantles that claim, highlighting five structural safeguards: Medicare’s entitlement design, its two‑trust‑fund architecture, the mandatory‑spending status, and the...
Roll-Out of Digital Eye Care Programme Continues Across Wales
The Welsh Government has completed the rollout of the OpenEyes electronic patient record and OPERAi electronic referral systems across all health boards, enabling real‑time clinical data sharing and standardized referral pathways. Glaucoma modules are now live in several boards, with...
Women Have Awaited a Revolution in Menopause. It Hasn’t Arrived.
The menopause market has surged to roughly $17 billion, driven by celebrity awareness and telehealth startups, yet scientific backing lags behind demand. Only about 6 % of private healthcare funding is allocated to women’s health, leaving many treatments unproven and clinical guidance...
Why Aren’t More Medical Technologies Designed for Children?
Despite rapid advances in adult medical technology, pediatric devices remain scarce. A recent review shows only 0.5% of FDA‑approved orthopaedic devices and 2% of AI radiology tools are labelled for children, while the UK spends just 5% of its health...
Blending AI with Human Wisdom Benefits Both Doctors and Patients
At Cedars‑Sinai’s virtual medical conference, Dr. Brennan Spiegel introduced the “blended intelligence” model, arguing that AI should augment—not replace—physicians. He highlighted smart‑glass heads‑up displays that stream real‑time electronic health record data into the exam room, and VR‑AI simulations designed to...
20 Future Portuguese HealthTech and MedTech Leaders
Portugal’s healthtech and medtech ecosystem has moved from a niche academic cluster to a mature, export‑driven sector, with over 4,700 active ventures and a 16 % growth rate. Venture capital surged to €886 million ($965 million) in 2024, fueling deep‑tech leaders in AI‑driven...
New Orexin‑Mimicking Agents Promise Disease‑Modifying Narcolepsy Therapy
Researchers announced a new class of orexin‑mimicking agents that directly address the neuropeptide deficiency underlying Type 1 narcolepsy. Highlighted in Nature Biotechnology, the drugs aim to replace missing orexin signaling, offering a potential disease‑modifying alternative to stimulant‑based symptom control.
Utah Lets an AI Chatbot Renew Some Psychiatric Prescriptions in New Pilot
Utah has signed a mitigation agreement with Legion Health to let an AI chatbot renew a limited set of psychiatric maintenance medications. The pilot, part of the state’s AI Learning Laboratory, restricts renewals to non‑controlled drugs such as SSRIs and...
Castle Rock Hormone Health Unveils Elite Longevity Program for Athletes and Executives
Castle Rock Hormone Health (CRHH) has launched an elite longevity program that blends hormone optimization, peptide therapy, cold‑plunge recovery and advanced monitoring for elite athletes, executives and creators. The clinic says the data‑driven regimen is designed to restore physiological balance...
A High Dose of Wegovy Will Cost $50 Less than Zepbound
Novo Nordisk introduced Wegovy HD, a high‑dose GLP‑1 injection priced at $399 per month, $50 less than Eli Lilly’s Zepbound at $449. The new 7.2 mg dose triples the previous 2.4 mg maximum, aiming to boost weight‑loss efficacy. Novo’s shares jumped 2.7% following...
Bangladesh Launches Emergency Measles‑rubella Campaign as Death Toll Tops 100 Children
Bangladesh is confronting a deadly measles outbreak that has claimed more than 100 children’s lives, most of them under nine months old. The government, together with UNICEF, has launched an emergency measles‑rubella vaccination drive targeting millions of children, aiming to...
Holivita’s AI Platform ‘Our Bodies Speak a Language’ Targets Preventive Health and Aging Research
Holivita’s AI-driven platform, dubbed “Our Bodies Speak a Language,” combines foundational biological data with large‑scale clinical records to uncover hidden health patterns. Scientist Dmitry Chebanov says the system could shift medicine from reactive treatment to proactive prevention, especially in aging...
Top Links 1066 Why US Health Care Is so Expensive. Hysteretic Noise. Targeting Pistachios & Family Values.
The article examines why health‑care costs in the United States remain dramatically higher than in peer economies. It points to hospitals charging inflated prices for routine services, a pricing structure that outpaces Medicare reimbursements and private‑insurance benchmarks. The piece suggests...
José Almeida Named CEO of Hologic After $18 B Blackstone‑TPG Buyout
Blackstone and TPG have installed José “Joe” Almeida, former Baxter International CEO, as chief executive of Hologic after completing an $18 billion buyout. The leadership change follows the private‑equity deal that valued Hologic at up to $79 per share and assumed...
Insmed Shelves Brinsupri in Skin Disease After Mid-Stage Flop
Insmed announced it is discontinuing development of Brinsupri for hidradenitis suppurativa (HS) after a Phase 2b trial failed to meet its primary endpoint. The drug, originally pursued for sinus inflammation, had already been shelved in that indication last year. The...
Prodrug‑Tethered Lipid Nanoparticles Deliver Dual mRNA‑Drug Therapy for Solid Tumors
Researchers in Michael Mitchell’s lab at the University of Pennsylvania have engineered lipid nanoparticles that simultaneously carry mRNA and a linked drug, creating a combined immunotherapy platform for solid tumors. The new prodrug‑tethered LNPs aim to activate immune cells while...
Exercise 60‑75 Min Daily Offsets Long Sitting Risk
Sitting a lot isn’t equally harmful for everyone. In this meta-analysis of >1 million adults, people who sat >8 h/day had no increased mortality risk if they also did about 60–75 min/day of moderate physical activity. (35.5 MET h/week). People doing...
Evotec Posts 103% Q4 EBITDA Jump as Investors Press for U.S. Listing of Just Biologics
Evotec SE reported a 103% rise in Q4 adjusted EBITDA to €58 million and a 14% revenue increase, driven by a €65 million Sandoz license payment. At the same time, activist investor MAK Capital is urging the firm to spin off its...
Know the FDA Process: Key to Biotech Investing
Investors should understand the #FDA regulatory process well. Here is a quick summary At each step investors should ask themselves if the company is developing things in a way that will satisfy the FDA Until a drug is approved the FDA is...
Falling Out of Love on Obesity Medicines?
Recent media stories claim experimental obesity drugs like retatrutide cause people to lose romantic feelings and could trigger a divorce surge. The Guardian and Telegraph pieces rely on TikTok anecdotes and indirect data from bariatric surgery, not clinical evidence. Experts...
Millions of Preterm Births Were Linked to Plastic Chemicals in New Study. Here’s What Experts Say
A new eClinicalMedicine study links exposure to the plasticizers DEHP and DiNP to roughly two million preterm births each year, accounting for more than 8% of global premature deliveries and about 74,000 newborn deaths. Researchers estimated exposure across 200 countries...
Diagnostic Dilemma: Woman's 'Biologically Implausible' Infection Led Her to Sneeze 'Worms' Out of Her Nose
Doctors in Greece documented a 58‑year‑old outdoor worker who expelled live larvae and a pupa of the sheep bot fly (Oestrus ovis) from her nasal passages. The parasites were surgically removed from her maxillary sinuses, marking a rare instance of...
NYC Health + Hospitals CEO Signals Willingness to Replace Radiologists with AI
NYC Health + Hospitals CEO Mitchell H. Katz announced the system is ready to replace many radiologists with AI once regulatory hurdles are cleared. He cited AI’s ability to interpret mammograms and X‑rays, promising lower labor costs and expanded screening...
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
Nurix Therapeutics reported Q1 2026 results, highlighting ongoing enrollment in the Phase 2 DAYBreak CLL‑201 trial and plans to launch a global Phase 3 DAYBreak CLL‑306 confirmatory study by mid‑year. The company also advanced a new tablet formulation of bexobrutideg to support an...
Bridging the Precision Gap: Accelerating Clinical Adoption of Companion Diagnostics in Oncology
Companion diagnostics (CDx) are central to precision oncology, yet clinical adoption lags due to lengthy evidence generation, regulatory hurdles, and reimbursement challenges. The article outlines three core bottlenecks—clinical validation, workflow integration, and payer coverage—that can stretch implementation timelines to a...
Midwives to Receive Anti-Racism Training
The Nursing and Midwifery Council (NMC) will embed anti‑racism principles into every UK midwifery degree program, aiming to curb the stark black maternal health crisis. Data from MBRRACE‑UK show black women are three times more likely to die during pregnancy...
Persistent Epstein-Barr Antibodies May Support MS Diagnosis
Researchers published in JAMA Neurology found that persistently elevated Epstein‑Barr virus (EBV) antibodies, specifically against EBNA‑1, appear in 96 % of multiple sclerosis (MS) patients but are rare in other neuroinflammatory diseases. The study analyzed about 2,000 patients with neurological conditions...
Jeito Capital Raises Record US$1.2bn to Bankroll European Biopharma’s Next Generation
Jeito Capital closed its second biopharma fund, Jeito II, at a record $1.2 bn (about €1 bn), making it the largest raise for an independent European biotech‑focused PE firm. The fund will back 15‑20 clinical‑stage companies, allocating roughly $162 m per position across obesity,...
NSAIDs: How Pain Relievers Affect Athletic Performance
What are NSAIDs? https://t.co/GPV7DlHNyD People often take NSAIDs, such as ibuprofen, to manage pain. In this blog, we explore the mechanisms of action of NSAIDs. We also explore how the mechanism may have important implications for athletes. https://t.co/5QGp4HCMTp
Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma
Hemispherian AS announced the initiation of a first‑in‑human Phase 1/2a trial of GLIX1 in patients with recurrent glioblastoma and other high‑grade gliomas. GLIX1 is an oral, first‑in‑class small‑molecule TET2 activator that induces tumor‑selective DNA damage and has demonstrated potent preclinical efficacy,...
Forty Years Strong: HMA Marks Four Decades Serving Self-Funded Employers
Healthcare Management Administrators (HMA) marked its 40th anniversary as a leading third‑party administrator for self‑funded employers. Founded in 1986, the firm emphasizes a people‑first culture, unbundled solutions, and deep broker partnerships. HMA reports medical and pharmacy cost trends consistently below...
RoosterBio and MineBio Team up to Expand MSC Solutions Access in China
RoosterBio has signed an exclusive distribution agreement with MineBio Life Sciences to bring its research‑grade and cGMP‑grade mesenchymal stem cell (MSC) and exosome bioprocessing media to China. MineBio has already secured import clearance, allowing rapid fulfillment of orders for both...
DHSC Pledges Plan to Halt Spiraling Cost of Clinical Negligence ‘This Autumn’
The UK Department of Health and Social Care (DHSC) will issue early proposals this autumn to curb the soaring cost of NHS clinical negligence claims, which have jumped from roughly $750 million in 2006‑07 to about $4.5 billion in 2024‑25. A National...
FDA Seeks Input on Digital Health Technologies in Clinical Investigations for Drugs and Biological Products
The FDA has issued a Federal Register notice seeking stakeholder input on the use of digital health technologies (DHTs) in clinical investigations for drugs and biologics. The agency asks for comments on regulatory challenges, guidance needs, and topics for future...
Crunch Time for the WHO
The International Health Reform Project (IHRP) has published the "Right to Health Sovereignty" reports, calling for a fundamental overhaul of the World Health Organization’s structure, financing and accountability. The analysis argues that the COVID‑19 response revealed mission creep, centralized emergency...
Controlling Diabetes without Insulin Injections Thanks to New Implant
MIT researchers unveiled an implantable device that houses insulin‑producing islet cells, shielding them from immune attack and supplying oxygen via an on‑board generator. In mouse studies the encapsulated cells survived at least 90 days, continuously secreting enough insulin to maintain...
Some Common IBS Treatments Are Linked to a Higher Risk of Death, Say Study
A new real‑world analysis of more than 650,000 U.S. adults with irritable bowel syndrome found that long‑term use of certain IBS drugs is linked to higher mortality. Antidepressants were associated with a 35 % increase in death risk, while the antidiarrheals...
Sequencing Method Exposes Hidden Gaps in Immune Signaling by Tracking RNA and Protein Together
University of Miami researchers unveiled CIPHER‑seq, a single‑cell platform that simultaneously profiles RNA and protein within individual immune cells. The method captures cytokine transcripts and their corresponding proteins, revealing the precise timing of immune activation. Compared with conventional workflows, CIPHER‑seq...
Urgent Care Clinics Move To Fill Abortion Care Gaps in Rural Areas
After the Planned Parenthood clinic in Marquette, Michigan shut down, urgent‑care physician Shawn Brown began offering medication abortions at her Marquette Medical Urgent Care. The clinic now provides up to four abortions per week, serving patients from a 500‑mile stretch...
Abortion Clinics Are Closing Nationwide. Could Urgent Care Help Fill the Gap?
After Planned Parenthood shut its Upper Peninsula clinic, Marquette Medical Urgent Care in Michigan began providing medication abortions in July. The urgent‑care, run by Dr. Shawn Brown and staffed by former Planned Parenthood physician Viktoria Koskenoja, now sees about four patients...
How to Spot Signs of Surgical Negligence and Prevent Medical Errors
The Joint Commission reports that wrong‑site surgeries and retained items account for nearly 15% of preventable hospital errors, highlighting a persistent surgical negligence problem. Staffing shortages and rising surgical volumes intensify operating‑room pressure, increasing the likelihood of real‑time mistakes. Early...